Sign in to continue:

Friday, February 27th, 2026

Goldman Sachs Group Inc 2025 Annual Report: Fair Value Hierarchy, Asset Classes, and Financial Instrument Disclosure





Goldman Sachs Group Inc. 2025 Annual 10-K: Key Investor Insights

Goldman Sachs Group Inc. 2025 Annual 10-K: Key Investor Insights

Goldman Sachs Group Inc. (NYSE: GS) has published its annual 10-K report for the fiscal year ended December 31, 2025. This comprehensive filing provides an in-depth look at the company’s financial position, equity structure, and valuation methodology, with a particular focus on its use of fair value measurements across a wide spectrum of assets and liabilities. The following analysis highlights the essential points investors and shareholders should know, especially those that could have a material impact on share price.

Key Points from the Report

  • Fair Value Measurement and Hierarchy:
    • Goldman Sachs categorizes its assets and liabilities according to the fair value measurement hierarchy (Levels 1, 2, and 3), as defined by U.S. GAAP. Level 3 assets, which rely on unobservable inputs, constitute a significant portion of the firm’s valuation process, especially in complex and illiquid instruments such as corporate loans, debt securities, and real estate-backed securities.
    • This significant exposure to Level 3 assets could introduce valuation uncertainty, potentially impacting the company’s book value, earnings volatility, and investor confidence.
  • Equity Structure and Capital Components:
    • The report details a variety of equity instruments, including common stock, multiple series of floating and fixed-to-floating rate preferred stock, and restricted stock units and employee stock options.
    • Movements in these equity components, such as new issuances, redemptions, or large-scale vesting of employee awards, could affect both share supply and the company’s overall capital structure.
  • Derivative and Risk Management Exposures:
    • Goldman Sachs holds substantial positions in derivatives across interest rate, commodity, equity, and credit risk contracts. These are valued using various risk and market-based models, and a notable portion falls under Level 3 of the fair value hierarchy.
    • Changes in market volatility, credit spreads, or model assumptions can have a material impact on the reported value of these instruments, with implications for both income and risk capital levels.
  • Accumulated Other Comprehensive Income (AOCI) and Treasury Stock:
    • The report provides breakdowns of AOCI and the company’s holdings in treasury stock, both of which can influence book value per share and the company’s capital management flexibility.
  • Price-Sensitive and Shareholder-Relevant Items:
    • The heavy reliance on Level 3 asset valuation, with key input assumptions such as expected dividend rates, prepayment rates, and terms, introduces a degree of subjectivity and risk that could be price-sensitive. Any changes in these inputs or in the external audit/review process could trigger revaluations, impacting quarterly or annual results.
    • Potential impairments, share-based compensation vestings, and changes in the mix of preferred and common equity also have the potential to move share price, especially if they signal shifts in capital strategy or risk appetite.

Details Investors Should Watch

  • Valuation Sensitivity: Investors should pay close attention to the assumptions used in valuing Level 3 assets, as these are subject to management judgment and market conditions. Even small changes in these assumptions (e.g., credit spreads, volatility, prepayment rates) could materially alter reported asset values and earnings.
  • Derivative Exposure: The size and complexity of Goldman Sachs’ derivative book means that the firm’s earnings and capital ratios remain exposed to sharp moves in global markets. Any indication of increased volatility or counterparty risk could be a catalyst for share price movement.
  • Equity Issuance or Buybacks: The report’s details on the company’s equity structure highlight the potential for share issuance, buybacks, or redemption of preferred shares. Significant activity in these areas can directly impact share price through dilution or signaling management’s view on intrinsic value.
  • Treasury Stock and AOCI Movements: Large buybacks or swings in AOCI (often driven by interest rate and market movements) can influence both per-share metrics and capital adequacy, potentially affecting investor sentiment.

Potential Share Price Movers

  • Model Risk and Fair Value Adjustments: Any material adjustment to Level 3 asset valuations, whether due to changes in inputs, external events, or audit findings, could result in significant earnings volatility and investor reaction.
  • Capital Strategy Changes: Shifts in the company’s approach to share-based compensation, preferred share redemptions, or capital allocation could be interpreted as changes in risk tolerance or management outlook.
  • Regulatory or Market Shocks: Given the complexity and opacity of some of Goldman Sachs’ assets and liabilities, any regulatory changes or market shocks affecting fair value measurement could have outsized impacts on reported results and, consequently, share price.

Conclusion

The 2025 10-K filing underscores Goldman Sachs’ reliance on sophisticated valuation models, particularly for illiquid and complex financial instruments. While this allows the firm to operate at the frontier of global finance, it also exposes shareholders to valuation risk and potential earnings volatility. Investors should closely monitor disclosures around Level 3 asset assumptions, derivative exposures, and equity structure changes, as these are the most likely drivers of future share price movement.



Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should review the full 10-K filing and consult with their financial advisor before making any investment decisions. The information presented is based solely on the company’s SEC filings and our analysis; no guarantee is made as to its accuracy or completeness.




View GOLDMAN SACHS GROUP INC Historical chart here



Nautilus Biotechnology Reports Q4 and FY2025 Financial Results and Progress Toward Commercial Launch in 2026

Nautilus Biotechnology Q4 and FY 2025 Earnings: Investor Analysis Nautilus Biotechnology Reports Q4 and Fiscal Year 2025 Results: Key Investor Insights Overview Nautilus Biotechnology, Inc. (NASDAQ: NAUT), a leader in single-molecule proteome analysis technology,...

Kinetik Holdings Reports Record 2025 Financial Results, Provides 2026 Guidance and Strategic Growth Outlook

Kinetik Holdings Reports Q4 and Full Year 2025 Results, Issues 2026 Guidance Kinetik Holdings Reports Record 2025 Results and Unveils Bullish 2026 Guidance Key Highlights from Q4 and Full Year 2025 Record Full-Year Adjusted...

Flotek Industries, Inc. 8-K Filing Summary, XBRL Data, and Company Information (2026)

Flotek Industries Announces Grants of Equity Awards to CEO and CFO HOUSTON, TX, February 24, 2026 – Flotek Industries, Inc. (NYSE: FTK) has announced that its Compensation Committee has approved significant equity awards for...

   Ad